Clinical Trial

Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies

CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical…

2 weeks ago

WCG Unveils ClinSphere® Trial IntelX, Raising the Bar for Smarter Trial Designs, Fewer Amendments & Faster Outcomes

CARY, N.C., Jan. 27, 2026 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical…

2 weeks ago

Clariness and SubjectWell Merge to Form Global, Full-Service Patient Recruitment Platform

BERLIN and AUSTIN, Texas, Jan. 27, 2026 /PRNewswire/ -- Clariness and SubjectWell announced their merger to form one of the…

2 weeks ago

Navidence Raises Seed Funding from Nina Capital and Grand Ventures to Bring Clarity to Real-World Data-Driven Clinical Research

AURORA, Colo., Jan. 27, 2026 /PRNewswire/ -- Navidence, a technology company focused on defining health data and supporting researchers in…

2 weeks ago

CNS Pharmaceuticals Issues Letter to Shareholders

Newly Appointed President & Chief Executive Officer, Rami Levin, Discusses Plans for a New Era at CNS PharmaceuticalsStrategic Focus, Pipeline…

2 weeks ago

Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel (Generic Plavix(R)) to Address Gastric Bleeding Risks

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.Clopidogrel, currently sold…

2 weeks ago

Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program

CAMBRIDGE, Mass., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for…

2 weeks ago

Imviva Biotech Receives FDA Orphan Drug Designation for CTD402 for the Treatment of T-Cell Leukemia and Lymphoma

BOSTON, Jan. 27, 2026 (GLOBE NEWSWIRE) --  Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today…

2 weeks ago

Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome

Confirmation Received from MHLW That QRX003 Qualifies for Both Orphan Drug Designation and Fast Track Regulatory Review Status Quoin Initiating…

2 weeks ago

CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer

VANCOUVER, Washington, Jan. 27, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company…

2 weeks ago